Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.88 USD | -0.67% | +9.02% | -9.33% |
04-18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
04-16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.33% | 2.13B | |
+9.15% | 106B | |
-1.08% | 104B | |
+6.93% | 23.25B | |
-11.55% | 22.5B | |
-7.10% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals : Earnings Flash (RXRX) RECURSION PHARMACEUTICALS Posts Q1 Revenue $2.6M